Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 8.59 | -2.28% | -0.20 |
RXRX closed down 2.28 percent on Wednesday, May 8, 2024, on 48 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | -2.28% | |
| BB Squeeze Started | Range Contraction | -2.28% | |
| Overbought Stochastic | Strength | -2.28% | |
| 200 DMA Resistance | Bearish | -3.91% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.91% | |
| NR7 | Range Contraction | -3.91% | |
| Weak + Overbought | Other | -3.91% |
| Alert | Time |
|---|---|
| Possible NR7 | about 14 hours ago |
| 60 Minute Opening Range Breakout | about 18 hours ago |
| Down 3% | about 18 hours ago |
| Fell Below Previous Day's Low | about 18 hours ago |
| Down 2 % | about 18 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 16.745 |
| 52 Week Low | 4.92 |
| Average Volume | 5,416,348 |
| 200-Day Moving Average | 9.12 |
| 50-Day Moving Average | 9.60 |
| 20-Day Moving Average | 8.12 |
| 10-Day Moving Average | 8.43 |
| Average True Range | 0.55 |
| RSI (14) | 48.72 |
| ADX | 14.66 |
| +DI | 27.29 |
| -DI | 24.28 |
| Chandelier Exit (Long, 3 ATRs) | 7.74 |
| Chandelier Exit (Short, 3 ATRs) | 8.80 |
| Upper Bollinger Bands | 9.19 |
| Lower Bollinger Band | 7.06 |
| Percent B (%b) | 0.72 |
| BandWidth | 26.25 |
| MACD Line | -0.18 |
| MACD Signal Line | -0.39 |
| MACD Histogram | 0.2113 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.09 | ||||
| Resistance 3 (R3) | 9.10 | 8.93 | 9.01 | ||
| Resistance 2 (R2) | 8.93 | 8.80 | 8.93 | 8.98 | |
| Resistance 1 (R1) | 8.76 | 8.72 | 8.85 | 8.76 | 8.95 |
| Pivot Point | 8.60 | 8.60 | 8.64 | 8.59 | 8.60 |
| Support 1 (S1) | 8.43 | 8.47 | 8.51 | 8.42 | 8.23 |
| Support 2 (S2) | 8.26 | 8.39 | 8.26 | 8.20 | |
| Support 3 (S3) | 8.09 | 8.26 | 8.17 | ||
| Support 4 (S4) | 8.09 |
